Truncating variants in p53AIP1 disrupting DNA damage-induced apoptosis are associated with prostate cancer risk.
Wang X, Wang F, Taniguchi K, Seelan RS, Wang L, Zarfas KE, McDonnell SK, Qian C, Pan K, Lu Y, Shridhar V, Couch FJ, Tindall DJ, Beebe-Dimmer JL, Cooney KA, Isaacs WB, Jacobsen SJ, Schaid DJ, Thibodeau SN, Liu W.
Wang X, et al. Among authors: couch fj.
Cancer Res. 2006 Nov 1;66(21):10302-7. doi: 10.1158/0008-5472.CAN-06-0638.
Cancer Res. 2006.
PMID: 17079449
Free article.